Gastric cancer is one of the most common malignancies of the digestive system,and the number of deaths continues to increase.The standardized management of the diagnosis and treatment of gastric cancer is challenging ...Gastric cancer is one of the most common malignancies of the digestive system,and the number of deaths continues to increase.The standardized management of the diagnosis and treatment of gastric cancer is challenging due to the great differences in the diagnosis and treatment of gastric cancer in different regions.The Gastric Cancer Expert Committee of the National Cancer Quality Control Center(NCQCC)identified a lack of authoritative quality control standards as an opportunity to utilize its multidisciplinary membership to improve the standardized diagnosis and treatment of gastric cancer.The Gastric Cancer Expert Committee of the NCQCC aims to promote quality control and national standardization,uniformity,and normalization of gastric cancer diagnosis and treatment,which ultimately improved the survival rate and quality of life of gastric cancer patients.A panel of experts with gastrointestinal cancer surgery,gastrointestinal cancer medicine,medical imaging,pathology and radiotherapy were drawn together and determined the quality control standards for the standardized diagnosis and treatment of gastric cancer.The authors then utilized a modified Delphi approach to generate consensus recommendations.展开更多
Esophageal carcinoma is one of the most common malignant tumors, especially in China which is the high incidence area. As a result of mild symptoms of early-stage esophageal cancer, the majority of patients cannot be ...Esophageal carcinoma is one of the most common malignant tumors, especially in China which is the high incidence area. As a result of mild symptoms of early-stage esophageal cancer, the majority of patients cannot be diagnosed until they develop to advanced cancer, and the treatment outcome of surgery or chemoradiotherapy is still unsatisfactory at present. The guidelines of esophageal cancer issued by National Comprehensive Cancer Network (NCCN) are regarded as important reference tools by clinical oncologists, and provide uniform criteria for the diagnosis and treatment of esophageal carcinoma. However, the guidelines are not always suitable for Chinese patients because the data come from European and American population which have significant ethnical difference from Chinese. We retrospectively analyzed the changes of treatment strategy of esophageal cancer in NCCN guidelines and the advance of treatment for esophageal carcinoma in China, aiming to provide our oncologists with new research ideas. We also hope to set up clinical cancer cooperation organizations, and release our own cancer guidelines to serve Chinese patients and oncologists.展开更多
Beside its poor prognosis and its late diagnosis, pancreatic cancer remains one of the most painful malignancies. Optimal management of pain in this cancer represents a real challenge for the oncologist whose objectiv...Beside its poor prognosis and its late diagnosis, pancreatic cancer remains one of the most painful malignancies. Optimal management of pain in this cancer represents a real challenge for the oncologist whose objective is to ensure a better quality of life to his patients. We aimed in this paper to review all the treatment modalities incriminated in the management of pain in pancreatic cancer going from painkillers, chemotherapy, radiation therapy and interventional techniques to agents under investigation and alternative medicine. Although specific guidelines and recommendations for pain management in pancreatic cancer are still absent, we present all the possible pain treatments, with a progression from medical multimodal treatment to radiotherapy and chemotherapy then interventional techniques in case of resistance. In addition, alternative methods such as acupuncture and hypnosis can be added at any stage and seems to contribute to pain relief.展开更多
Background: The incidence of cancer pain in patients with malignant tumors is relatively high, and pain control is poor, which is closely related to many factors, especially the nursing way. Objective: To explore the ...Background: The incidence of cancer pain in patients with malignant tumors is relatively high, and pain control is poor, which is closely related to many factors, especially the nursing way. Objective: To explore the effect of standardized nursing model on pain control in patients with malignant tumors. Methods: 50 patients with malignant tumors treated in the Affiliated Hospital of Chengde Medical College from January to December in 2021 were randomly divided into 25 cases in the control group and 25 cases in the observation group. The pain control and medication compliance of the two groups were compared. Results: There was no difference in the corresponding score of admission pain between the two groups (P > 0.05), and the pain score of the observation group was lower than that of the control group (P P Conclusion: Standardized cancer pain nursing can ease the pain of patients, and the medication compliance is better.展开更多
Five-year survival rate for patients with all cancers combined, in China, is only 30.9%, which is much lower than those in developed countries. The three main reasons for the low cancer curative rates in China include...Five-year survival rate for patients with all cancers combined, in China, is only 30.9%, which is much lower than those in developed countries. The three main reasons for the low cancer curative rates in China include differences in the spectrum of cancer types, in early detection rates, and in the percentage of cancer patients receiving standardized treatment between China and developed countries.The most important mechanism for improving the curative rate is to improve early detection rates of major cancers in China using novel and affordable technologies that can be operated at home by the patients themselves.This attempt could be helpful in setting up a practical example for other developing countries with limited medical resources and a limited number of healthcare practitioners.展开更多
Objective: To explore the efficacy of Tongkuaixiao Babu plaster (痛块消巴剂, TKXBBP)in treating cancer pain. Methods: In the clinical observation, sixty-five patients with moderate or severe cancer pain were randomly ...Objective: To explore the efficacy of Tongkuaixiao Babu plaster (痛块消巴剂, TKXBBP)in treating cancer pain. Methods: In the clinical observation, sixty-five patients with moderate or severe cancer pain were randomly divided into two groups: 32 in the treated group (TKXBBP group) and 33 in the control group (Bucinnazine group). The therapeutic effects in relieving pain, improving quality of life (QOL),and the rate of satisfaction the patients felt of the two groups were compared respectively. Results: TKXBBP was effective in treating cancer pain. There wasn't any statistically significant difference in total effective rate (P>0.05), but the statistical difference was significant in obvious remission rate (P<0.05) between the treated and control group, and the effect on serious pain shown in the treated group was better than that of the control group (P<0.05). The difference in the initiation time of relieving cancer pain was insignificant (P>0.05), while in the remission period, the treated group showed its treatment was obviously superior to that of the control group (P<0.05). TKXBBP showed better effect in the improvement of QOL (P<0.05)and satisfaction rate, with significant difference between the treated and the control groups (P<0.01). Conclusion: TKXBBP's effect in treating cancer pain was obvious, its application was safe and convenient. It was shown that the external treatment with this kind of Chinese medicine had great advantage in treating cancer pain.展开更多
BACKGROUND Colorectal cancer(CRC)is a prevalent malignant tumor involving adenomas that develop into malignant lesions.Carcinoembryonic antigen(CEA)is a non-specific serum biomarker upregulated in CRC.The concentratio...BACKGROUND Colorectal cancer(CRC)is a prevalent malignant tumor involving adenomas that develop into malignant lesions.Carcinoembryonic antigen(CEA)is a non-specific serum biomarker upregulated in CRC.The concentration of CEA is modulated by tumor stage and grade,tumor site in the colon,ploidy status,and patient smoking status.This study aimed to evaluate current evidence regarding the diagnostic power of CEA levels in the early detection of CRC recurrence in adults.AIM To evaluate current evidence regarding the diagnostic power of CEA levels in the early detection of CRC recurrence in adults.METHODS A systematic search was performed using four databases:MEDLINE,Cochrane Trials,EMBASE,and the Web of Science.The inclusion criteria were as follows:Adult patients aged≥18 years who had completed CRC curative treatment and were followed up postoperatively;reporting the number of CRC recurrences as an outcome;and randomized,clinical,cohort,and case-control study designs.Studies that were not published in English and animal studies were excluded.The following data were extracted by three independent reviewers:Study design,index tests,follow-up,patient characteristics,and primary outcomes.All statistical analyses were performed using the RevMan 5.4.1.RESULTS A total of 3232 studies were identified,with 73 remaining following the elimination of duplicates.After screening on predetermined criteria,12 studies were included in the final analysis.At a reference standard of 5 mg/L,CEA detected only approximately half of recurrent CRCs,with a pooled sensitivity of 59%(range,33%–83%)and sensitivity of 89%(range,58%–97%).CONCLUSION CEA is a significant marker for CRC diagnosis.However,it has insufficient sensitivity and specificity to be used as a single biomarker of early CRC recurrence,with an essential proportion of false negatives.展开更多
目的探究标准化急诊预检分诊模式在区域性胸痛中心中的应用价值。方法选取2020年7月—2022年1月陆军第七十三集团军医院未实施标准化急诊预检分诊模式时间段内接诊的100例急性胸痛患者设为对照组,将2022年2月—2023年6月陆军第七十三集...目的探究标准化急诊预检分诊模式在区域性胸痛中心中的应用价值。方法选取2020年7月—2022年1月陆军第七十三集团军医院未实施标准化急诊预检分诊模式时间段内接诊的100例急性胸痛患者设为对照组,将2022年2月—2023年6月陆军第七十三集团军医院开展标准化急诊预检分诊模式后接诊的100例急性胸痛患者为研究组。对比2组患者抢救指标、临床效果、急诊工作效率以及不良反应发生情况差异。结果研究组患者的预检分诊时间[(2.03±0.21)minvs.(3.05±0.29)min]、首份心电图时间[(5.06±1.01)minvs.(6.23±1.51)min]、开放静脉通路时间[(9.11±2.01)minvs.(11.63±2.01)min]、床旁测试(point-of-care-testing,POCT)+检验报告时间[(18.98±2.65)min vs.(23.65±2.81)min]均明显短于对照组(P<0.05)。研究组患者的首次医疗接触(first medical contact,FMC)至经皮冠状动脉介入治疗(percutaneous coronary intervention,PCI)(FMC-to-B)[(43.20±3.65)minvs.(56.96±5.18)min]、自送到医院至接受正规治疗总时间(total time from hospital to receiving formal treatment,D-to-B)[(72.36±6.23)min vs.(110.15±13.23)min]以及肌钙蛋白Ⅰ获得时间[(21.02±2.65)minvs.(31.05±3.11)min]均显著低于对照组(P<0.05)。研究组患者的急诊处置时间[(10.23±2.09)min vs.(16.32±3.01)min]以及急诊候诊时间[(0.98±0.31)min vs.(3.55±0.59)min]均明显短于对照组(P<0.05)。2组患者在预检分诊准确率比较,差异无统计学意义(P>0.05)。研究组患者出现心律失常1例,心力衰竭1例,不良反应总发生率为2.00%(2/100),显著低于对照组患者的9.00%(9/100)(P<0.05)。结论对急性胸痛患者开展标准化急诊预检分诊模式有助于提高患者预检分诊效率、改善临床治疗效果,对降低不良反应发生率具有积极意义。展开更多
OBJECTIVE To observe the efficacy of high-intensity focused ultrasound (HIFU) in the treatment of late-stage pancreatic cancer. METHODS Sixteen patients with advanced pancreatic cancer received HIFU therapy.Evaluation...OBJECTIVE To observe the efficacy of high-intensity focused ultrasound (HIFU) in the treatment of late-stage pancreatic cancer. METHODS Sixteen patients with advanced pancreatic cancer received HIFU therapy.Evaluation of efficacy was made on the basis of changes in clinical symptoms and variations in the tumor echo and size. RESULTS Clinical symptoms such as pain were significantly alleviated,echo of the tumor was enhanced with B-US and the quality of life such as eating,sleeping and mental status was markedly improved;no serious complications were observed. CONCLUSION The use of HIFU in the treatment of advanced pancreatic cancer is feasible and safe.It is effective in killing the carcinoma cells and alleviating pain.This technique may offer non-invasive therapy for the treatment of patients with late-stage pancreatic cancer.展开更多
目的评价基于时效性激励理论的快速康复外科(Enhanced recovery after surgery,ERAS)护理对甲状腺癌手术患者疼痛、舒适度和治疗费用的影响。方法根据入院时间先后次序,选取2021年6月至9月在本院住院行甲状腺癌切除术患者80例设为对照组...目的评价基于时效性激励理论的快速康复外科(Enhanced recovery after surgery,ERAS)护理对甲状腺癌手术患者疼痛、舒适度和治疗费用的影响。方法根据入院时间先后次序,选取2021年6月至9月在本院住院行甲状腺癌切除术患者80例设为对照组,实施ERAS;选取2021年10月至12月在本院住院行甲状腺癌切除术患者80例设为试验组,实施基于时效性激励理论的ERAS。比较术后两组患者疼痛、舒适度及住院费用的差异。结果试验组患者疼痛得分及其程度低于对照组,两组比较,差异均有统计学意义(均P<0.01)。试验组患者舒适度得分及其程度高于对照组,两组比较,差异均有统计学意义(均P<0.001)。试验组治疗费用低于对照组,两组比较,差异有统计学意义(P<0.05)。结论基于时效性激励理论的ERAS可降低甲状腺癌术后患者疼痛程度及治疗费用并提高其舒适度,值得在临床推广。展开更多
基金supported by“Beijing Municipal Administration of Hospitals Incubating Program”(No.PX2018043)。
文摘Gastric cancer is one of the most common malignancies of the digestive system,and the number of deaths continues to increase.The standardized management of the diagnosis and treatment of gastric cancer is challenging due to the great differences in the diagnosis and treatment of gastric cancer in different regions.The Gastric Cancer Expert Committee of the National Cancer Quality Control Center(NCQCC)identified a lack of authoritative quality control standards as an opportunity to utilize its multidisciplinary membership to improve the standardized diagnosis and treatment of gastric cancer.The Gastric Cancer Expert Committee of the NCQCC aims to promote quality control and national standardization,uniformity,and normalization of gastric cancer diagnosis and treatment,which ultimately improved the survival rate and quality of life of gastric cancer patients.A panel of experts with gastrointestinal cancer surgery,gastrointestinal cancer medicine,medical imaging,pathology and radiotherapy were drawn together and determined the quality control standards for the standardized diagnosis and treatment of gastric cancer.The authors then utilized a modified Delphi approach to generate consensus recommendations.
文摘Esophageal carcinoma is one of the most common malignant tumors, especially in China which is the high incidence area. As a result of mild symptoms of early-stage esophageal cancer, the majority of patients cannot be diagnosed until they develop to advanced cancer, and the treatment outcome of surgery or chemoradiotherapy is still unsatisfactory at present. The guidelines of esophageal cancer issued by National Comprehensive Cancer Network (NCCN) are regarded as important reference tools by clinical oncologists, and provide uniform criteria for the diagnosis and treatment of esophageal carcinoma. However, the guidelines are not always suitable for Chinese patients because the data come from European and American population which have significant ethnical difference from Chinese. We retrospectively analyzed the changes of treatment strategy of esophageal cancer in NCCN guidelines and the advance of treatment for esophageal carcinoma in China, aiming to provide our oncologists with new research ideas. We also hope to set up clinical cancer cooperation organizations, and release our own cancer guidelines to serve Chinese patients and oncologists.
文摘Beside its poor prognosis and its late diagnosis, pancreatic cancer remains one of the most painful malignancies. Optimal management of pain in this cancer represents a real challenge for the oncologist whose objective is to ensure a better quality of life to his patients. We aimed in this paper to review all the treatment modalities incriminated in the management of pain in pancreatic cancer going from painkillers, chemotherapy, radiation therapy and interventional techniques to agents under investigation and alternative medicine. Although specific guidelines and recommendations for pain management in pancreatic cancer are still absent, we present all the possible pain treatments, with a progression from medical multimodal treatment to radiotherapy and chemotherapy then interventional techniques in case of resistance. In addition, alternative methods such as acupuncture and hypnosis can be added at any stage and seems to contribute to pain relief.
文摘Background: The incidence of cancer pain in patients with malignant tumors is relatively high, and pain control is poor, which is closely related to many factors, especially the nursing way. Objective: To explore the effect of standardized nursing model on pain control in patients with malignant tumors. Methods: 50 patients with malignant tumors treated in the Affiliated Hospital of Chengde Medical College from January to December in 2021 were randomly divided into 25 cases in the control group and 25 cases in the observation group. The pain control and medication compliance of the two groups were compared. Results: There was no difference in the corresponding score of admission pain between the two groups (P > 0.05), and the pain score of the observation group was lower than that of the control group (P P Conclusion: Standardized cancer pain nursing can ease the pain of patients, and the medication compliance is better.
基金supported by grants from the National Natural Science Foundation of China(No.81472386,No.81672872)the National High Technology Research and Development Program of China(863 Program)(No.2012AA02A501)+1 种基金the Science and Technology Planning Project of Guangdong Province,China(No.2014B020212017,No.20148050504004 and No.2015B050501005)the Provincial Natural Science Foundation of Guangdong,China(No.2016A030311011)
文摘Five-year survival rate for patients with all cancers combined, in China, is only 30.9%, which is much lower than those in developed countries. The three main reasons for the low cancer curative rates in China include differences in the spectrum of cancer types, in early detection rates, and in the percentage of cancer patients receiving standardized treatment between China and developed countries.The most important mechanism for improving the curative rate is to improve early detection rates of major cancers in China using novel and affordable technologies that can be operated at home by the patients themselves.This attempt could be helpful in setting up a practical example for other developing countries with limited medical resources and a limited number of healthcare practitioners.
文摘Objective: To explore the efficacy of Tongkuaixiao Babu plaster (痛块消巴剂, TKXBBP)in treating cancer pain. Methods: In the clinical observation, sixty-five patients with moderate or severe cancer pain were randomly divided into two groups: 32 in the treated group (TKXBBP group) and 33 in the control group (Bucinnazine group). The therapeutic effects in relieving pain, improving quality of life (QOL),and the rate of satisfaction the patients felt of the two groups were compared respectively. Results: TKXBBP was effective in treating cancer pain. There wasn't any statistically significant difference in total effective rate (P>0.05), but the statistical difference was significant in obvious remission rate (P<0.05) between the treated and control group, and the effect on serious pain shown in the treated group was better than that of the control group (P<0.05). The difference in the initiation time of relieving cancer pain was insignificant (P>0.05), while in the remission period, the treated group showed its treatment was obviously superior to that of the control group (P<0.05). TKXBBP showed better effect in the improvement of QOL (P<0.05)and satisfaction rate, with significant difference between the treated and the control groups (P<0.01). Conclusion: TKXBBP's effect in treating cancer pain was obvious, its application was safe and convenient. It was shown that the external treatment with this kind of Chinese medicine had great advantage in treating cancer pain.
文摘BACKGROUND Colorectal cancer(CRC)is a prevalent malignant tumor involving adenomas that develop into malignant lesions.Carcinoembryonic antigen(CEA)is a non-specific serum biomarker upregulated in CRC.The concentration of CEA is modulated by tumor stage and grade,tumor site in the colon,ploidy status,and patient smoking status.This study aimed to evaluate current evidence regarding the diagnostic power of CEA levels in the early detection of CRC recurrence in adults.AIM To evaluate current evidence regarding the diagnostic power of CEA levels in the early detection of CRC recurrence in adults.METHODS A systematic search was performed using four databases:MEDLINE,Cochrane Trials,EMBASE,and the Web of Science.The inclusion criteria were as follows:Adult patients aged≥18 years who had completed CRC curative treatment and were followed up postoperatively;reporting the number of CRC recurrences as an outcome;and randomized,clinical,cohort,and case-control study designs.Studies that were not published in English and animal studies were excluded.The following data were extracted by three independent reviewers:Study design,index tests,follow-up,patient characteristics,and primary outcomes.All statistical analyses were performed using the RevMan 5.4.1.RESULTS A total of 3232 studies were identified,with 73 remaining following the elimination of duplicates.After screening on predetermined criteria,12 studies were included in the final analysis.At a reference standard of 5 mg/L,CEA detected only approximately half of recurrent CRCs,with a pooled sensitivity of 59%(range,33%–83%)and sensitivity of 89%(range,58%–97%).CONCLUSION CEA is a significant marker for CRC diagnosis.However,it has insufficient sensitivity and specificity to be used as a single biomarker of early CRC recurrence,with an essential proportion of false negatives.
文摘目的探究标准化急诊预检分诊模式在区域性胸痛中心中的应用价值。方法选取2020年7月—2022年1月陆军第七十三集团军医院未实施标准化急诊预检分诊模式时间段内接诊的100例急性胸痛患者设为对照组,将2022年2月—2023年6月陆军第七十三集团军医院开展标准化急诊预检分诊模式后接诊的100例急性胸痛患者为研究组。对比2组患者抢救指标、临床效果、急诊工作效率以及不良反应发生情况差异。结果研究组患者的预检分诊时间[(2.03±0.21)minvs.(3.05±0.29)min]、首份心电图时间[(5.06±1.01)minvs.(6.23±1.51)min]、开放静脉通路时间[(9.11±2.01)minvs.(11.63±2.01)min]、床旁测试(point-of-care-testing,POCT)+检验报告时间[(18.98±2.65)min vs.(23.65±2.81)min]均明显短于对照组(P<0.05)。研究组患者的首次医疗接触(first medical contact,FMC)至经皮冠状动脉介入治疗(percutaneous coronary intervention,PCI)(FMC-to-B)[(43.20±3.65)minvs.(56.96±5.18)min]、自送到医院至接受正规治疗总时间(total time from hospital to receiving formal treatment,D-to-B)[(72.36±6.23)min vs.(110.15±13.23)min]以及肌钙蛋白Ⅰ获得时间[(21.02±2.65)minvs.(31.05±3.11)min]均显著低于对照组(P<0.05)。研究组患者的急诊处置时间[(10.23±2.09)min vs.(16.32±3.01)min]以及急诊候诊时间[(0.98±0.31)min vs.(3.55±0.59)min]均明显短于对照组(P<0.05)。2组患者在预检分诊准确率比较,差异无统计学意义(P>0.05)。研究组患者出现心律失常1例,心力衰竭1例,不良反应总发生率为2.00%(2/100),显著低于对照组患者的9.00%(9/100)(P<0.05)。结论对急性胸痛患者开展标准化急诊预检分诊模式有助于提高患者预检分诊效率、改善临床治疗效果,对降低不良反应发生率具有积极意义。
基金a grant from Medical Scientific Research Foundation of Guangdong Province,China (No.A2007481)
文摘OBJECTIVE To observe the efficacy of high-intensity focused ultrasound (HIFU) in the treatment of late-stage pancreatic cancer. METHODS Sixteen patients with advanced pancreatic cancer received HIFU therapy.Evaluation of efficacy was made on the basis of changes in clinical symptoms and variations in the tumor echo and size. RESULTS Clinical symptoms such as pain were significantly alleviated,echo of the tumor was enhanced with B-US and the quality of life such as eating,sleeping and mental status was markedly improved;no serious complications were observed. CONCLUSION The use of HIFU in the treatment of advanced pancreatic cancer is feasible and safe.It is effective in killing the carcinoma cells and alleviating pain.This technique may offer non-invasive therapy for the treatment of patients with late-stage pancreatic cancer.
文摘目的评价基于时效性激励理论的快速康复外科(Enhanced recovery after surgery,ERAS)护理对甲状腺癌手术患者疼痛、舒适度和治疗费用的影响。方法根据入院时间先后次序,选取2021年6月至9月在本院住院行甲状腺癌切除术患者80例设为对照组,实施ERAS;选取2021年10月至12月在本院住院行甲状腺癌切除术患者80例设为试验组,实施基于时效性激励理论的ERAS。比较术后两组患者疼痛、舒适度及住院费用的差异。结果试验组患者疼痛得分及其程度低于对照组,两组比较,差异均有统计学意义(均P<0.01)。试验组患者舒适度得分及其程度高于对照组,两组比较,差异均有统计学意义(均P<0.001)。试验组治疗费用低于对照组,两组比较,差异有统计学意义(P<0.05)。结论基于时效性激励理论的ERAS可降低甲状腺癌术后患者疼痛程度及治疗费用并提高其舒适度,值得在临床推广。